β¨ Medicine Consents Schedule
27 MARCH 2008
NEW ZEALAND GAZETTE, No. 64
Schedule
Product:
Arabloc
Active Ingredient:
Leflunomide 10mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Aventis Intercontinental, Compeigne, France
Note: This consent is valid for two years from 23 March 2008.
Product:
Arabloc
Active Ingredient:
Leflunomide 100mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Aventis Intercontinental, Compeigne, France
Note: This consent is valid for two years from 23 March 2008.
Product:
Arabloc
Active Ingredient:
Leflunomide 20mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Aventis Intercontinental, Compeigne, France
Note: This consent is valid for two years from 23 March 2008.
Product:
Arabloc
Active Ingredient:
Leflunomide 10mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Aventis Intercontinental, Compeigne, France
Note: This consent is valid for two years from 23 March 2008.
Product:
Arava
Active Ingredient:
Leflunomide 10mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Aventis Intercontinental, Compeigne, France
Note: This consent is valid for two years from 23 March 2008.
Product:
Arava
Active Ingredient:
Leflunomide 100mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Aventis Intercontinental, Compeigne, France
Note: This consent is valid for two years from 23 March 2008.
Product:
Arava
Active Ingredient:
Leflunomide 20mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Aventis Intercontinental, Compeigne, France
Note: This consent is valid for two years from 23 March 2008.
Product:
Leflunomide Winthrop
Active Ingredient:
Leflunomide 10mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Aventis Intercontinental, Compeigne, France
Note: This consent is valid for two years from 18 May 2008.
Product:
Leflunomide Winthrop
Active Ingredient:
Leflunomide 100mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Aventis Intercontinental, Compeigne, France
Note: This consent is valid for two years from 18 May 2008.
1857
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2008, No 64
Gazette.govt.nz —
NZ Gazette 2008, No 64
β¨ LLM interpretation of page content
π₯
Renewal of Provisional Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social WelfareMedicines Act 1981, Provisional Consent, Distribution, New Medicines, Arabloc, Arava, Leflunomide Winthrop, Leflunomide, Film coated tablet, sanofi-aventis new zealand limited, Aventis Intercontinental, Compeigne, France